AI肌肉骨骼成像医疗科技公司Medimaps与Radiobotics达成合并协议。
AI musculoskeletal imaging medtechs Medimaps and Radiobotics pen merger deal
生命科学资讯
生物技术与制药领域的最新动态
Esperion以7500万美元预付款收购Corstasis及其水肿鼻喷雾剂。
Esperion to buy Corstasis and its nasal spray for edema for $75M upfront
Champlain Investment Partners LLC持有安捷伦科技公司价值1.1497亿美元的股票 - MarketBeat
Champlain Investment Partners LLC Has $114.97 Million Stock Holdings in Agilent Technologies, Inc. $A - MarketBeat
尚普兰投资伙伴有限责任公司出售94,439股沃特世公司$WAT股份 - MarketBeat
Champlain Investment Partners LLC Sells 94,439 Shares of Waters Corporation $WAT - MarketBeat
罗氏：可持续运营、供应链与人工智能在健康领域的应用——可持续发展杂志
Roche: Sustainable Operations, Supply Chains & AI in Health - Sustainability Magazine
GLP-1类药物通过松弛紧缩血管，有助于啮齿动物心脏病发作后的恢复。
GLP-1s support heart attack recovery in rodents by relaxing tight blood vessels
Illumina的TruPath罕见病计划是否重塑其临床测序投资叙事？
Is Illumina’s (ILMN) TruPath Rare Disease Push Reframing Its Clinical Sequencing Investment Narrative? - simplywall.st
龙沙集团：美国投资者错过的瑞士生物科技悄然上涨——特别报道
Lonza Group AG: Quiet Rally In Swiss Biotech That U.S. Investors Are Missing - AD HOC NEWS
大规模心脏遗传学检测：TruGenome心血管疾病检测与CardioSeq临床试验 - Illumina
Cardiogenetic testing at scale: the TruGenome Cardiovascular Disease Test and CardioSeq Clinical Trial - Illumina
安捷伦科技在逆风中展现稳健增长势头 - TipRanks
Agilent Technologies Signals Steady Growth Amid Headwinds - TipRanks
安捷伦股价暴跌2.64%，交易量降至4.1亿美元，日交易活跃度排名第322位，财报不及预期但财报后现反弹行情——Bitget
Agilent's Stock Plummets 2.64% as Trading Volume Dips to $0.41B, Ranking 322 in Daily Trading Activity Amid Earnings Miss and Post-Earnings Rally - Bitget
美国卫生与公众服务部禁用Claude AI工具，特朗普寻求全面禁止政府使用Anthropic技术。
HHS bans Claude AI tool as Trump seeks full government blacklisting of Anthropic
迈向猕猴社会容忍度等级的神经解剖学与认知基础研究
Toward neuroanatomical and cognitive foundations of macaque social tolerance grades
安捷伦科技股价周一表现逊于同行——MarketWatch
Agilent Technologies Inc. stock underperforms Monday when compared to competitors - MarketWatch
安捷伦科技股价周一表现逊于竞争对手 - MarketWatch
Agilent Technologies Inc. stock underperforms Monday when compared to competitors - MarketWatch
摩根士丹利下调安捷伦目标股价，因估值倍数过高 - Investing.com
Morgan Stanley cuts Agilent stock price target on valuation multiples - Investing.com
沃特世公司（WAT）投资者展望：评估潜在24.63%上涨空间——DirectorsTalk访谈
Waters Corporation (WAT) Investor Outlook: Evaluating A Potential 24.63% Upside - DirectorsTalk Interviews
赛默飞世尔（NYSE: TMO）人力资源主管为缴纳税款处置股份 - 股票泰坦
Thermo Fisher (NYSE: TMO) HR chief disposes shares to cover tax liability - Stock Titan
摩根士丹利因估值倍数下调安捷伦股票目标价 - Investing.com
Morgan Stanley cuts Agilent stock price target on valuation multiples - Investing.com
10x Genomics (TXG) CEO Serge Saxonov获重大限制性股票单位奖励 - 股票泰坦
Major RSU grant to 10x Genomics (TXG) CEO Serge Saxonov - Stock Titan